Terms: = Liver cancer AND TOP2A, TOP2, TP2A
92 results:
1. Immunotherapy and drug sensitivity predictive roles of a novel prognostic model in hepatocellular carcinoma.
Gao X; Ren X; Wang F; Ren X; Liu M; Cui G; Liu X
Sci Rep; 2024 Apr; 14(1):9509. PubMed ID: 38664521
[TBL] [Abstract] [Full Text] [Related]
2. Macroscopic inhibition of DNA damage repair pathways by targeting AP-2α with LEI110 eradicates hepatocellular carcinoma.
Wang C; Zhao Z; Zhao Y; Zhao J; Xia L; Xia Q
Commun Biol; 2024 Mar; 7(1):342. PubMed ID: 38503825
[TBL] [Abstract] [Full Text] [Related]
3. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating top2a.
Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
[TBL] [Abstract] [Full Text] [Related]
4. Identification of topoisomerase 2A as a novel bone metastasis-related gene in liver hepatocellular carcinoma.
Feng J; Wei X; Liu Y; Zhang Y; Li G; Xu Y; Zhou P; Zhang J; Han X; Zhang C; Zhang Y; Wang G
Aging (Albany NY); 2023 Nov; 15(22):13010-13040. PubMed ID: 37980167
[TBL] [Abstract] [Full Text] [Related]
5. Network based approach to identify interactions between Type 2 diabetes and cancer comorbidities.
Nayan SI; Rahman MH; Hasan MM; Raj SMRH; Almoyad MAA; Liò P; Moni MA
Life Sci; 2023 Dec; 335():122244. PubMed ID: 37949208
[TBL] [Abstract] [Full Text] [Related]
6. Role of top2a and CDC6 in liver cancer.
Jia W; Liu X; Zhang Z
Medicine (Baltimore); 2023 Oct; 102(42):e35604. PubMed ID: 37861550
[TBL] [Abstract] [Full Text] [Related]
7. Gene Expression and Metadata Based Identification of Key Genes for Hepatocellular Carcinoma Using Machine Learning and Statistical Models.
Hasan MAM; Maniruzzaman M; Shin J
IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(6):3786-3799. PubMed ID: 37812547
[TBL] [Abstract] [Full Text] [Related]
8. cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the top2a coding sequence.
Ruan Y; Chen T; Zheng L; Cai J; Zhao H; Wang Y; Tao L; Xu J; Ji L; Cai X
Int J Biol Sci; 2023; 19(14):4608-4626. PubMed ID: 37781045
[TBL] [Abstract] [Full Text] [Related]
9. [Screening and validation of pivotal genes in hepatitis B virus-associated hepatocellular carcinoma].
Wu YJ; Liu S; Tian YQ; Fan ZJ; Zhang L; Liu SY
Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):869-876. PubMed ID: 37723070
[No Abstract] [Full Text] [Related]
10. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
[TBL] [Abstract] [Full Text] [Related]
11. Identification of ferroptosis and drug resistance related hub genes to predict the prognosis in Hepatocellular Carcinoma.
Li C; Cui X; Li Y; Guo D; He S
Sci Rep; 2023 May; 13(1):8681. PubMed ID: 37248280
[TBL] [Abstract] [Full Text] [Related]
12. CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma.
Tang K; Li X; Mo J; Chen Y; Huang C; Li T; Luo T; Zhong Z; Jiang Y; Yang D; Mo W
Sci Rep; 2023 May; 13(1):7452. PubMed ID: 37156819
[TBL] [Abstract] [Full Text] [Related]
13. Differentially expressed discriminative genes and significant meta-hub genes based key genes identification for hepatocellular carcinoma using statistical machine learning.
Hasan MAM; Maniruzzaman M; Shin J
Sci Rep; 2023 Mar; 13(1):3771. PubMed ID: 36882493
[TBL] [Abstract] [Full Text] [Related]
14. CircADSS contributes to hepatocellular carcinoma development by regulating miR-431-5p/top2a.
Gong J; Du C; Sun N; Xiao X; Wu H
Clin Exp Pharmacol Physiol; 2023 May; 50(5):415-424. PubMed ID: 36786410
[TBL] [Abstract] [Full Text] [Related]
15. HBV-infected hepatocellular carcinoma can be robustly classified into three clinically relevant subgroups by a novel analytical protocol.
Cheng Z; Li L; Zhang Y; Ren Y; Gu J; Wang X; Zhao H; Lu H
Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36736372
[TBL] [Abstract] [Full Text] [Related]
16. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma.
Chen C; Liang T; Wu Q; Zhou Z; Zhang M; Feng D; Tao J; Si T; Cai M
Comput Math Methods Med; 2022; 2022():2940654. PubMed ID: 36578460
[TBL] [Abstract] [Full Text] [Related]
17. Comparative RNA-Sequencing Analysis Reveals High Complexity and Heterogeneity of Transcriptomic and Immune Profiles in Hepatocellular Carcinoma Tumors of Viral (HBV, HCV) and Non-Viral Etiology.
Paslaru L; Bindea G; Nastase A; Sorop A; Zimbru C; Herlea V; Hrehoret D; Brasoveanu V; Zamfir R; Dima S; Popescu I
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557005
[TBL] [Abstract] [Full Text] [Related]
18. Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis.
Li Y; Li J; He T; Song Y; Wu J; Wang B
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553600
[TBL] [Abstract] [Full Text] [Related]
19. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
Yu Y; Cheng J; Mei CZ; Dai YZ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
[TBL] [Abstract] [Full Text] [Related]
20. Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma.
Pallerla SR; Hoan NX; Rachakonda S; Meyer CG; Van Tong H; Toan NL; Linh LTK; Giang DP; Kremsner PG; Bang MH; Song LH; Velavan TP
BMC Med Genomics; 2022 Nov; 15(1):235. PubMed ID: 36345011
[TBL] [Abstract] [Full Text] [Related]
[Next]
